Symptomatology and exploration methods of pulmonary tumours in children.
The paediatric, thoracic and genetic surgeons are still highly interested in the appearance of primitive and metastasised pulmonary tumours in new-born children and babies. Once the human genome was decoded, the studies for individualising the genes responsible for the appearance of pulmonary malignant tumours or with other localization have been intensified. The diagnosis within the first 15 weeks of pregnancy will allow the parents to make a decision regarding the future evolution. Genetic surgery will eliminate in the future the drama of pregnancy discontinuity by the possibility of replacing the genes responsible with the growth of these tumours. At present, the symptomatology allows detecting the tumour at approximately 9-12 months since its appearance, and Rx/anatomopathological exploration can confirm or deny the diagnosis, offering information on its primitive or metastasised, benign or malignant, operable or non-operable character.
Burnei
Gh
G
M.S.Curie Emergency Hospital for Children, Paediatric Orthopaedics Clinic, Bucharest, Romania. mscburnei@yahoo.com
Georgescu
Ileana
I
Vlad
C
C
Gavrliu
St
S
Drăghici
Isabel-Magdalena
IM
Dan
Daniela
D
Burnei
C
C
D000293:Adolescent; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D003952:Diagnostic Imaging; D005260:Female; D006801:Humans; D007223:Infant; D008175:Lung Neoplasms / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy; D008297:Male; D009367:Neoplasm Staging; D016896:Treatment Outcome